CORRELATION BETWEEN NT-PROBNP AND ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS WITH ARRHYTHMIAS

Duong Ha Khanh Linh1,, Lam Vinh Nien2, Tran Thanh Vinh1
1 Cho Ray Hospital
2 University of Medicine and Pharmacy at Ho Chi Minh City

Nội dung chính của bài viết

Tóm tắt

Background: Arrhythmias are a significant public health burden, associated with increased morbidity and mortality. NT-proBNP, a biomarker of cardiac stress, has been shown to be elevated in various cardiovascular conditions. Objective: This study aimed to determine NT-proBNP concentrations in a cohort of patients with arrhythmias and evaluate the correlation between echocardiographic indices such as EF, EDV, ESV, and left ventricular dimensions (LVEDD, LVESD) and NT-proBNP concentrations in this patient population. Subjects and Methods: This study included 272 patients with various types of arrhythmias. Echocardiographic parameters, including EF, EDV, ESV, LVEDD, and LVESD were obtained. NT-proBNP levels were measured in all patients. Spearman's rank correlation coefficient was used to assess the relationship between NT-proBNP and echocardiographic parameters. Multivariate regression analysis was performed to adjust for potential confounders. Results: The median NT-proBNP level was 44.1 pmol/L. 69.5% of patients had levels above 15 pmol/L. Patients with ventricular arrhythmias had higher median NT-proBNP levels compared to those with non-ventricular arrhythmias (94.6 vs. 42.3 pmol/L), although not statistically significant. Spearman's rank correlation analysis revealed a significant inverse correlation between NT-proBNP and EF. Furthermore, positive correlations were observed between NT-proBNP and LVESD and LVEDD. Multivariate regression analysis, adjusting for age, eGFR, and heart failure status, confirmed independent associations between NT-proBNP and EF, ESV, LVEDD and LVESD. Conclusions: Higher NT-proBNP levels were associated with reduced EF and increased left ventricular dimensions, even after adjusting for potential confounders. These findings suggest that NT-proBNP may be a useful biomarker for assessing cardiac function and identifying patients at higher risk for adverse outcomes in this population.

Chi tiết bài viết

Tài liệu tham khảo

1. R. D. Ianos et al., "Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus," Medicina (Kaunas), vol. 60, no. 11, Nov 8 2024, doi: 10.3390/medicina60111841.
2. C. Ceyhan, S. Unal, C. Yenisey, T. Tekten, and F. B. Ceyhan, "The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients," Int J Cardiovasc Imaging, vol. 24, no. 3, pp. 253-9, Mar 2008, doi: 10.1007/s10554-007-9256-2.
3. M. N. Islam, M. S. Chowdhury, G. K. Paul, R. C. Debnath, and S. S. Shakil, "Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction," Mymensingh Med J, vol. 28, no. 2, pp. 333-346, Apr 2019. [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/31086148.
4. W. S. Kim and S. H. Park, "Correlation between N-Terminal Pro-Brain Natriuretic Peptide and Doppler Echocardiographic Parameters of Left Ventricular Filling Pressure in Atrial Fibrillation," J Cardiovasc Ultrasound, vol. 19, no. 1, pp. 26-31, Mar 2011, doi: 10.4250/jcu.2011.19.1.26.
5. T. A. McDonagh et al., "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure," Eur Heart J, vol. 42, no. 36, pp. 3599-3726, Sep 21 2021, doi: 10.1093/eurheartj/ehab368.
6. J. H. Cho, "Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction," Korean Circ J, vol. 52, no. 4, pp. 251-264, Apr 2022, doi: 10.4070/kcj.2021.0420.
7. V. Waldmann, S. Barra, and E. Marijon, "Ventricular arrhythmias and sudden cardiac death in heart failure with mildly reduced or preserved ejection fraction: knowledge gaps," Eur Heart J, vol. 44, no. 8, pp. 678-679, Feb 21 2023, doi: 10.1093/eurheartj/ehad001.
8. I. Koniari, E. Artopoulou, D. Velissaris, N. Kounis, and G. Tsigkas, "Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management," J Geriatr Cardiol, vol. 18, no. 5, pp. 376-397, May 28 2021, doi: 10.11909/j.issn.1671-5411.2021.05.003.